AMOYTOP(SH:688278) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-10-28 20:22Core Viewpoint - The company, Amoytop Biologics Co., Ltd., is set to hold a Q3 2025 earnings presentation on November 5, 2025, to discuss its operational results and financial status, allowing investors to engage and ask questions [2][3][5]. Group 1: Earnings Presentation Details - The earnings presentation will take place on November 5, 2025, from 13:00 to 14:00 [5][6]. - Investors can participate online via the Shanghai Stock Exchange Roadshow Center [4][5]. - Questions from investors can be submitted between October 29 and November 4, 2025, through the Roadshow Center or via the company's email [2][7]. Group 2: Stock Incentive Plan - The company announced the listing of 1,389,480 shares related to its 2024 restricted stock incentive plan, which will be available for trading starting October 30, 2025 [11][13]. - The total number of shares listed under this plan is 1,389,480, and the number of participants in the incentive plan is 600 [17][18]. - The shares represent approximately 0.34% of the company's total share capital prior to the allocation, and the impact on the company's financial results is not expected to be significant [20].